Abstract
Crystallographic structures of wild-type and mutant NOS isoforms complexed with substrate, intermediate, inhibitor, cofactor, and cofactor analogs are currently available. However, because of the high level of amino-acid conservation and the consequent similarity in dimeric quaternary structure as well as in the active site of NOS isoforms, structure-based isoform-selective inhibitor design is still a very challenging task. Nevertheless, the comprehension of the structural determinants for selectivity among the isoforms is fundamental for the design of further potent and more selective inhibitors. Computational techniques, based on the knowledge of the tridimensional structure of the isozymes, have been already applied to understand the significant isoform selectivity shown by some compounds. Collectively these structure-based approaches, in combination with SAR studies, have been able to explain the structural reasons of this selectivity.
Keywords: Drug design, NOS inhibitors, selective, modeling, computational
Current Medicinal Chemistry
Title: Computational Studies of Competitive Inhibitors of Nitric Oxide Synthase (NOS) Enzymes: Towards the Development of Powerful and Isoform-Selective Inhibitors
Volume: 13 Issue: 16
Author(s): A. Tafi, L. Angeli, G. Venturini, M. Travagli, F. Corelli and M. Botta
Affiliation:
Keywords: Drug design, NOS inhibitors, selective, modeling, computational
Abstract: Crystallographic structures of wild-type and mutant NOS isoforms complexed with substrate, intermediate, inhibitor, cofactor, and cofactor analogs are currently available. However, because of the high level of amino-acid conservation and the consequent similarity in dimeric quaternary structure as well as in the active site of NOS isoforms, structure-based isoform-selective inhibitor design is still a very challenging task. Nevertheless, the comprehension of the structural determinants for selectivity among the isoforms is fundamental for the design of further potent and more selective inhibitors. Computational techniques, based on the knowledge of the tridimensional structure of the isozymes, have been already applied to understand the significant isoform selectivity shown by some compounds. Collectively these structure-based approaches, in combination with SAR studies, have been able to explain the structural reasons of this selectivity.
Export Options
About this article
Cite this article as:
Tafi A., Angeli L., Venturini G., Travagli M., Corelli F. and Botta M., Computational Studies of Competitive Inhibitors of Nitric Oxide Synthase (NOS) Enzymes: Towards the Development of Powerful and Isoform-Selective Inhibitors, Current Medicinal Chemistry 2006; 13 (16) . https://dx.doi.org/10.2174/092986706777585031
DOI https://dx.doi.org/10.2174/092986706777585031 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Need for Nutritious Convenience Foods for the Elderly Population: A Review
Current Nutrition & Food Science Biomedical Applications of Poly(Lactic Acid)
Recent Patents on Regenerative Medicine Treatment of Hypertension in Heart Failure with Preserved Ejection Fraction
Current Hypertension Reviews Melatonin and Hypothalamic-Pituitary-Gonadal Axis
Current Medicinal Chemistry Neonatal Ultrasound in Transport
Current Pediatric Reviews Functional Signaling Biases in G Protein-Coupled Receptors: Game Theory and Receptor Dynamics
Mini-Reviews in Medicinal Chemistry Necrotizing Enterocolitis: Clinical Features, Histopathological Characteristics, and Genetic Associations
Current Pediatric Reviews MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance
Current Drug Targets Endocannabinoid Blockade and the Cardiovascular System
Current Drug Therapy Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Current Pharmaceutical Design The Epidemiology of Sepsis
Current Pharmaceutical Design Management of Acute Aluminum Phosphide Poisoning: Has Anything Changed?
Drug Metabolism Letters L-Arginine Transport in Disease
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Therapeutic Effects of Renal Denervation on Renal Failure
Current Neurovascular Research Recent Advances in the MCRs Synthesis of Chromenes: A Review
Current Organic Chemistry Catestatin: A Master Regulator of Cardiovascular Functions
Current Medicinal Chemistry Diamidine Activity Against Trypanosomes: The State of the Art
Current Molecular Pharmacology A Review of Cardiogenic Shock in Acute Myocardial Infarction
Current Cardiology Reviews Guanylation of Amines with Isonitriles in the Presence of Iodine
Letters in Organic Chemistry Synthesis and in vitro Evaluation of the Anticancer Potential of New Aminoalkanol Derivatives of Xanthone
Anti-Cancer Agents in Medicinal Chemistry